PFKL and hepatocellular carcinoma: Moreover, it was observed that DT‐13 could inhibit Phosphofructokinase‐1 liver (PFKL) type via c‐myc signaling to modulate the aerobic glycolysis, proliferation, and apoptosis of HCC.